Article
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Clinical endocrinology - 1 Apr 2008
Costa Angela M, Herrero Agustín, Fresno Manuel F, Heymann Jonas, Alvarez José Antonio, Cameselle-Teijeiro Jose, García-Rostán Ginesa
Abstract excerpt
PURPOSE: BRAF(V600E) mutation represents the most common oncogenic event in sporadic papillary thyroid cancer (PTC). There are, however, significant discrepancies regarding the overall frequency, its prevalence in PTC-variants, and its relationship with clinico-pathological parameters of poor outcome. Moreover, the impact of BRAF(V600E) mutants on tumour-related patient's death has not been evaluated. DESIGN: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
